1. Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017;63(4):278-85. [
link]
2. Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. [
DOI:10.3390/ijms20061475] [
PMID] [
PMCID]
3. Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377-85. [
DOI:10.1038/jid.2012.339] [
PMID]
4. Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis. 2018;102(5S):18-20. [
link]
5. Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. 2013;168(6):1303-10. [
DOI:10.1111/bjd.12230] [
PMID]
6. Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the united states. JAMA Dermatol. 2021;157(8):940-6. [
DOI:10.1001/jamadermatol.2021.2007] [
PMID]
7. Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590. [
DOI:10.1136/bmj.m1590] [
PMID] [
PMCID]
8. Lee JY, Kang S, Park JS, Jo SJ. Prevalence of psoriasis in korea: A population-based epidemiological study using the korean national health insurance database. Ann Dermatol. 2017;29(6):761-7. [
DOI:10.5021/ad.2017.29.6.761] [
PMID] [
PMCID]
9. Mohd Affandi A, Khan I, Ngah Saaya N. Epidemiology and clinical features of adult patients with psoriasis in malaysia: 10-year review from the malaysian psoriasis registry (2007-2016). Dermatol Res Pract. 2018;2018:4371471. [
DOI:10.1155/2018/4371471] [
PMID] [
PMCID]
10. Fernández-Armenteros JM, Gómez-Arbonés X, Buti-Solé M, Betriu-Bars A, Sanmartin-Novell V, Ortega-Bravo M, et al. Epidemiology of psoriasis; A population-based study. Actas Dermo-Sifiliográficas (English Edition). 2019;110(5):385-92. [
DOI:10.1016/j.adengl.2019.01.014]
11. Goldblum OM. Epidemiology of psoriasis over time and by age and gender. Br J Dermat. 2021;184(2):e34. [
DOI:10.1111/bjd.19725]
12. Ejaz A, Raza N, Iftikhar N, Iftikhar A, Farooq M. Presentation of early onset psoriasis in comparison with late onset psoriasis: A clinical study from Pakistan. Indian J Dermatol Venereol Leprol. 2009;75(1):36-40. [
DOI:10.4103/0378-6323.45218] [
PMID]
13. Armstrong AW. Psoriasis. JAMA Dermatol. 2017;153(9):956. [
DOI:10.1001/jamadermatol.2017.2103] [
PMID]
14. Yildizhan IK, SÜRGÜN E. Epidemiological and clinical characteristics, treatments, and comorbidities in elderly patients with psoriasis and the evaluation of patients according to the age of onset. Turk J Geriatr. 2020;23(2):216-23. [
DOI:10.31086/tjgeri.2020.156]
15. James WD, Elston D, McMahon PJ. Andrews' diseases of the skin clinical atlas e-book. 1st Edition. Amsterdam: Elsevier Health Sciences; 2016. [
link]
16. Mitra AD, Mitra A. Clinical presentation of psoriasis. London, UK: IntechOpen; 2013. [
link]
17. Sarac G, Koca TT, Baglan T. A brief summary of clinical types of psoriasis. North Clin Istanb. 2016;3(1):79-82. [
link]
18. Armstrong AW, Villanueva Quintero DG, Echeverría CM, Gu Y, Karunaratne M, Reyes Servín O. Body region involvement and quality of life in psoriasis: Analysis of a randomized controlled trial of adalimumab. Am J Clin Dermatol. 2016;17(6):691-9. [
DOI:10.1007/s40257-016-0229-x] [
PMID] [
PMCID]
19. Bożek A, Reich A. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017;26(5):851-6. [
DOI:10.17219/acem/69804] [
PMID]
20. Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM, Global Psoriasis Atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184(2):243-58. [
DOI:10.1111/bjd.19169] [
PMID]
21. Egeberg A, Skov L, Gislason GH, Thyssen JP, Mallbris L. Incidence and prevalence of psoriasis in denmark. Acta Derm Venereol. 2017;97(7):808-12. [
DOI:10.2340/00015555-2672] [
PMID]
22. Queiro R, Tejón P, Alonso S, Coto P. Age at disease onset: A key factor for understanding psoriatic disease. Rheumatology. 2013;53(7):1178-85. [
DOI:10.1093/rheumatology/ket363] [
PMID]
23. Koo JYM, Wu JJ, Gottlieb AB, Levin EC, Leon A, editors. Moderate to severe psoriasis. 4th Edition. United States: CRC Press; 2014. [
DOI:10.1201/b16633]
24. Takahashi H, Nakamura K, Kaneko F, Nakagawa H, Iizuka H, Japanese Society for Psoriasis Research. Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008. J Dermatol. 2011;38(12):1125-9. [
DOI:10.1111/j.1346-8138.2010.01145.x] [
PMID]
25. Dogra A, Arora AK. Nail psoriasis: The journey so far. Indian J Dermatol. 2014;59(4):319-33. [
DOI:10.4103/0019-5154.135470] [
PMID] [
PMCID]
26. Wrone DA. Clinical dermatology: A color guide to diagnosis and therapy. JAMA. 2012;307(14):1534. [
DOI:10.1001/jama.2012.438]
27. Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736-40. [
DOI:10.1136/annrheumdis-2012-201706] [
PMID]
28. Farnaghi F, Moin A. One year survey of hospitalized psoriatic patients and their treatment in Razi Hospital. Tehran Univ MedJ. 1998;56(2):83-8. [Persian] [
link]